Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors, stimulants |
Mechanism CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors), CD47 inhibitors(Cluster of differentiation 47 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) + [2] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | China | - |